Bone Anchored Awareness Day was established in 2021 as a non-branded day to raise awareness, celebrate bone anchored hearing as a treatment, and give voice to users around the globe.
Read MoreOticon is working with otolaryngologists, audiologists, and bone anchored implant users to increase understanding and appreciation of the value of bone anchored implants in advance of the proposed CMS changes to withdraw its current coverage policy for bone anchored hearing devices.
Read MoreOticon Medical recently held its first scientific meeting, where international clinicians, researchers, and opinion leaders in otology, neurotology, and audiology gathered to discuss the latest advances and the future of bone anchored hearing solutions.
Read MoreOticon Medical presented several papers and conducted workshops at The Third International Symposium on Bone Conduction Hearing – Craniofacial Osseointegration (OSSEO), held in Sarasota, Fla.
Read More
Evidence suggests that, for some patient populations, bone anchored hearing systems are the primary or preferred treatment of choice over other options.
Read More
Functional gain, in conjunction with an appropriate skull simulator, can yield data that is both reliable and valid for the BAHA and other bone conduction aids. Frequency-specific information can be determined within reasonable clinical time requirements to verify or make adjustments to these fittings.
Read More
Cochlear’s Smart Hearing Alliance allows your patients the ability to stream directly to both ears from a compatible iOS or Android device using their Nucleus 7 or Kanso 2 Sound Processor and a compatible ReSound hearing aid.
Read More
The FDA has cleared two new Oticon Medical products for marketing in the US: The Minimally Invasive Ponto Surgery (MIPS), an update of the tissue preservation surgery for use with the company’s Ponto System; and the Ponto BHX Implant, which has a laser-ablated titanium surface that promotes a faster and stronger bonding to bone, and is designed to increase the strength of the bone-to-implant interface by more than 150%.
Read More
The Oticon Medical Great Debate in BAHS 2015 event stimulated knowledge sharing, opinions and insights on best treatments and approaches in bone-anchored hearing care.
Read More
The Center for Medicare and Medicaid Services (CMS) has released its final rule, stating that it will maintain Medicare coverage of auditory osseointegrated implants (AOIs), reversing its earlier proposal to have AOIs classified as hearing aids (thereby eliminating coverage for them).
Read More
The Centers for Medicare and Medicaid Services proposed a new rule that would effectively end coverage for people who need bone-anchored hearing solutions—systems that have traditionally been covered by Medicare.
Read More
The Centers for Medicare and Medicaid Services (CMS) proposed a new rule on July 11 that would effectively end coverage for people who need bone anchored hearing solutions. The deadline for clinicians and their patients to submit comments ends September 2.
Read MoreBAHA’s appear to be helpful in improving hearing and quality of life in children with hearing loss in one or both ears, according to a report the Archives of Otolaryngology Head & Neck Surgery.
Read MoreThe researchers reviewed the charts of 23 children and teens with single-sided deafness who received bone-anchored hearing aids over a 3-year period. Scores on hearing tests and questionnaires improved significantly following surgery, according to the report.
Read MoreWilliam Demant Holding introduces Oticon Medical, a new business that focuses on the development and marketing of bone-anchored hearing solutions.
Read More